Dosimetric Adjustments for Interspecies Extrapolation of Inhaled Poorly Soluble Particles (PSP)

Abstract

Direct calculation of delivered dose in the species of interest potentially affects the magnitude of an uncertainty factor needed to address extrapolation of laboratory animal data to equivalent human exposure scenarios, thereby improving the accuracy of human health risk estimates. Development of an inhalation reference concentration (RfC) typically involves extrapolation of an effect level observed in a laboratory animal exposure study to a level of exposure in humans that is not expected to result in an appreciable health risk. The default dose metric used for respiratory effects is the average deposited dose normalized by regional surface area. However, the most relevant dose metric is generally one that is most closely associated with the mode of action leading to the response. Critical factors in determining the best dose metric to characterize the dose-response relationship include the following: the nature of the biological response being examined; the magnitude, duration, and frequency of the intended exposure scenario; and the mechanisms by which the toxicants exert their effects. Dosimetry models provide mechanistic descriptions of these critical factors and can compute species-specific dose metrics. In this article, various dose metrics are postulated based on potential modes of action for poorly soluble particles (PSP). Dosimetry models are used to extrapolate the internal dose metric across species and to estimate the human equivalent concentration (HEC). Dosimetry models for the lower respiratory tract (LRT) of humans and rats are used to calculate deposition and retention using the principle of particle mass balance in the lower respiratory tract. Realistic asymmetric lung geometries using detailed morphometric measurements of the tracheobronchial (TB) airways in rats and humans are employed in model calculations. Various dose metrics are considered for the TB and pulmonary (P) regions. Because time is an explicit parameter incorporated in species-specific constants such as mucociliary clearance rates used in the models, the impact of the application of optimal model structures to refine adjustments and assumptions used in default risk assessment approaches to address exposure duration are discussed. HEC estimates were found for particles ranging in sizes that corresponded to existing toxicity studies of PSP (0.3 to 5 microm). A dose metric expressed as number of particles per biologically motivated normalization factors (e.g., number of ventilatory units, number of alveoli, and number of macrophages) was lower than the current default of mass normalized to regional surface area for either deposited or retained dose estimates. Retained dose estimates were lower than deposited dose estimates across all particle sizes evaluated. Dose metrics based on the deposited mass per unit area in small and large airways of the TB region indicate HECs of 1 to 5 times those of rats: that is, an equivalent exposure to humans which would achieve the same internal dose as in the rat would be 1 to 5 times greater. H...

Role of Macrophage-induced Inflammation in Mesothelioma

“…Pathologic tissue responses such as edema, inflammation, or fibrosis might potentially affect translocation and retention of particulates in the body, as well as properties of particles themselves including dose, dimensions and biopersistence. Although similarities exist between animal models and humans concerning physiological processes such as interstitial fluid dynamics and lymphatic flow, there are also anatomical differences such as in visceral pleural thickness (Tyler, 1983), as well as physiological differences such as of macrophage size and function, that need to be taken into account when comparing across animal species and when extrapolating from animals to humans (Jarabek et al, 2005;Maxim & McConnell, 2001). Rodents and humans also differ in particle respirability (Mossman et al, 2011) and this limits the use of rodent models for human risk assessment based on fiber dimensions (Lippmann & Schlesinger, 1984;Lippmann et al, 1980).…”

New developments in aerosol dosimetry

“…The minute ventilation, and hence the delivered dose, will vary significantly among subjects with different body size, including children (ICRP, 1994;Ginsberg et al, 2008). Jarabek et al (2005) presented methods for dose extrapolations among various species based on current knowledge.…”

Inhaled aerosol particle dosimetry in mice: A review

“…The initial inhaled dose is often normalized to body weight, but it may be also normalized to a distinct property of the biological target, such as tissue mass, surface area, or volume. In spite of its limitations, this initial dose is most often used to correlate with the biological effects in a toxicology study, and to perform extrapolation calculations (Jarabek et al, 2005).…”